Ultrastructural Analysis of Chitosan Antibacterial Activity against Clinical Isolates of Staphylococcus aureus and Escherichia coli

The continuous search for an antimicrobial agent led to the identification of potential antimicrobial biomaterials based on polymers naturals, such as chitosan (CS). However, the mechanism of action of antibacterial activity of CS for gram-positive and gram-negative bacteria was not completely elucidated. The aim of this work is to report the antibacterial activity of CS through ultrastructural analyses of the clinical isolates Staphylococcus aureus and Escherichia coli by Transmission Electron Microscopy. The CS has a bactericidal action against S. aureus and E. coli which alters its cellular ultrastructure, such as with collapsed cell walls, condensed chromatin and the increase of intracellulares structures like vacuoles and cell debris. In this way, the CS represents a potential model for the future design of antibacterial in order to control bacterial resistance of patients in hospital settings.

[1]  R. Amorim,et al.  Antimicrobial Effects of Native Chitosan against Opportunistic Gram-negative Bacteria , 2011 .

[2]  W. Ahn,et al.  The use of chitosan as a condensing agent to enhance emulsion-mediated gene transfer. , 2005, Biomaterials.

[3]  A. Curtis,et al.  Application of Nanoparticle Technologies in the Combat against Anti-Microbial Resistance , 2018, Pharmaceutics.

[4]  Gerrit Borchard,et al.  Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis. , 2004, Vaccine.

[5]  M. Radmacher,et al.  Bacterial turgor pressure can be measured by atomic force microscopy. , 2000, Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics.

[6]  P. François,et al.  Development of in vitro resistance to chitosan is related to changes in cell envelope structure of Staphylococcus aureus. , 2017, Carbohydrate polymers.

[7]  Zi-rong Xu,et al.  Preparation and antibacterial activity of chitosan nanoparticles. , 2004, Carbohydrate research.

[8]  C. Tran,et al.  Facile synthesis, characterization, and antimicrobial activity of cellulose-chitosan-hydroxyapatite composite material: a potential material for bone tissue engineering. , 2013, Journal of biomedical materials research. Part A.

[9]  Liping Sun,et al.  Chitosan kills bacteria through cell membrane damage. , 2004, International journal of food microbiology.

[10]  Adam J Friedman,et al.  Nanotechnology as a therapeutic tool to combat microbial resistance. , 2013, Advanced drug delivery reviews.

[11]  Shivika Das,et al.  Fabrication of porous chitosan/silver nanocomposite film and its bactericidal efficacy against multi-drug resistant (MDR) clinical isolates , 2013 .

[12]  E. Çeli̇k,et al.  Investigations of antibacterial activity of chitosan in the polymeric composite coatings , 2017 .

[13]  Ming Kong,et al.  Antibacterial mechanism of chitosan microspheres in a solid dispersing system against E. coli. , 2008, Colloids and surfaces. B, Biointerfaces.

[14]  Shiguo Chen,et al.  Integration of lysozyme into chitosan nanoparticles for improving antibacterial activity. , 2017, Carbohydrate polymers.

[15]  Peter Eaton,et al.  Atomic force microscopy study of the antibacterial effects of chitosans on Escherichia coli and Staphylococcus aureus. , 2008, Ultramicroscopy.

[16]  Jerome J. Schentag,et al.  The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database. , 2005, Archives of internal medicine.

[17]  S. Ghosh,et al.  The antibacterial properties of a novel chitosan-Ag-nanoparticle composite. , 2008, International journal of food microbiology.

[18]  Lisbeth Ilium,et al.  Chitosan and Its Use as a Pharmaceutical Excipient , 1998, Pharmaceutical Research.

[19]  Jiangfeng Zhu,et al.  Study on antimicrobial activity of chitosan with different molecular weights , 2003 .

[20]  M. Másson,et al.  Antimicrobial activity of piperazine derivatives of chitosan , 2008 .

[21]  U. Guliyeva,et al.  Chitosan microparticles containing plasmid DNA as potential oral gene delivery system. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[22]  B. Mishra,et al.  Mannose-conjugated chitosan nanoparticles loaded with rifampicin for the treatment of visceral leishmaniasis. , 2014, Carbohydrate polymers.

[23]  Yi Liu,et al.  Water-solubility of chitosan and its antimicrobial activity , 2006 .

[24]  Yinglei Xu,et al.  Antibacterial activity of chitosan tripolyphosphate nanoparticles loaded with various metal ions , 2009 .

[25]  Fei Yang,et al.  Synthesis and characterization of chitosan derivatives with dual-antibacterial functional groups. , 2015, International journal of biological macromolecules.

[26]  Jintae Lee,et al.  Development of gold nanoparticles coated with silica containing the antibiofilm drug cinnamaldehyde and their effects on pathogenic bacteria , 2017, International journal of nanomedicine.

[27]  Jianhui Li,et al.  Antibacterial activity and mechanism of chitosan with ultra high molecular weight. , 2016, Carbohydrate polymers.

[28]  S. Ruan,et al.  Modeling Nosocomial Infections of Methicillin-Resistant Staphylococcus aureus with Environment Contamination* , 2017, Scientific Reports.